Nino Giunashvili

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Anti Inflammatory Drugs

Cardiovascular Events

Top Venues

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nino Giunashvili, Jeremiah Mbuotidem Thomas, Csaba András Schvarcz, Pedro Henrique Leroy Viana, Kenan Aloss, Syeda Mahak Zahra Bokhari, Zoltán Koós, Dániel Bócsi, Enikő Major, Andrea Balogh, Zoltán Benyó, Peter Hamar
Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models. Molecular oncology (2024)
Nino Giunashvili, Jeremiah Mbuotidem Thomas, Csaba András Schvarcz, Pedro Henrique Leroy Viana, Kenan Aloss, Syeda Mahak Zahra Bokhari, Zoltán Koós, Dániel Bócsi, Enikő Major, Andrea Balogh, Zoltán Benyó, Peter Hamar
Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models. Molecular oncology 18 (4) (2024)
Nino Giunashvili, Jeremiah Mbuotidem Thomas, Csaba András Schvarcz, Pedro Henrique Leroy Viana, Kenan Aloss, Syeda Mahak Zahra Bokhari, Zoltán Koós, Dániel Bócsi, Enikő Major, Andrea Balogh, Zoltán Benyó, Peter Hamar
Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models. Molecular oncology 18 (4) (2024)
Nino Giunashvili, Jeremiah Mbuotidem Thomas, Csaba András Schvarcz, Pedro Henrique Leroy Viana, Kenan Aloss, Syeda Mahak Zahra Bokhari, Zoltán Koós, Dániel Bócsi, Enikő Major, Andrea Balogh, Zoltán Benyó, Peter Hamar
Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models. Molecular oncology 18 (4) (2024)